Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors

Oncolytic vvDD administered i.v. shows activity in preclinical models of pediatric malignancies that are resistant to many currently available treatments. Our data support further evaluation of vvDD virotherapy for refractory pediatric solid tumors.